Practice of Clinical Pharmacists Participating in the Treatment of a Case of Severe Ulcerative Colitis dur-ing Late Pregnancy
10.6039/j.issn.1001-0408.2016.08.40
- VernacularTitle:临床药师参与1例妊娠晚期重度溃疡性结肠炎患者的治疗实践
- Author:
Yi XU
;
He SHU
;
Qian WANG
;
Li ZHANG
;
Jianjiang XU
- Publication Type:Journal Article
- Keywords:
Ulcerative colitis;
Late pregnancy;
Clinical pharmacist;
Pharmaceutical care
- From:
China Pharmacy
2016;27(8):1131-1132,1133
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To discuss the role of clinical pharmacist participating in drug therapy for severe ulcerative colitis (UC)during late pregnancy. METHODS:Clinical pharmacists participated in the therapy for a UC patients during late pregnancy, assisted the doctors to optimize and improve drug therapy plan from antidiarrheal,anti-intestinal inflammation,regulating intestinal flora,recovering damaged mucosa;suggested regimen was as follows:montmorillonite powder 3 g,pr,qd,to avoid drug interac-tion;hydrocortisone 100 mg,ivgtt,bid to resist intestinal inflammation;prednisone 30 mg,po,qd+20 mg,po,qn,instead after symptom relieved;stopping taking Bifid triple viable capsules,supplementing Human serum albumin injection,Nutrients,Potassi-um chloride injection,Concentrated sodium chloride injection,etc. RESULTS:The suggestion provided by clinical pharmacists was adopted by doctors,and the patient was recovered. There was no significant difference in the intelligence development,body weight and height charge between born baby boy and infants with same month age. CONCLUSIONS:Clinical pharmacists assist physician to optimize and improve drug therapy plan to promote rational drug use in the clinic and guarantee the safety of drug use.
